Prior to joining Eris, Ranganathan was Commercial Director, Women's Health, Metabolics, and International Business at Abbott India Limited
e brings over 27+ years of rich pharmaceutical experience
Vonoprozan is a novel potassium-competitive acid blocker used for the treatment of acid related disorders
He will be responsible for leading all the activities related to the Research & Development (Formulations) Division of the company
The scheme is subject to statutory and regulatory approvals as may be necessary.
Empagliflozin is a novel sodium glucose co-transporter-2 (SGLT-2) inhibitor, which is useful for improving glycaemic control in adults with type-2 diabetes mellitus.
ICICI Direct gives a preview on the earnings narrative for Q3FY22
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
The injunction order has been passed against Natco Pharma, Torrent Pharmaceuticals, Eris Lifesciences and Windlas Biotech
Subscribe To Our Newsletter & Stay Updated
